Skip to content
OpenCapital
Get started

CareDx CDNA Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
NeoGenomics logo
NeoGenomicsNEO
$883.35M-5.6%
Personalis, Inc. logo
Personalis, Inc.PSNL
$631.91M+125%
GeneDx Holdings logo
GeneDx HoldingsWGS
$1.88B-22.8%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$3.36B+66.0%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

$889.1Mmarket cap+$24.5Mtotal debt−$78.5Mcash and equivalents=$835.14M

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's enterprise value?
CareDx (CDNA) reported enterprise value of $835.14M in Q1 2026.
How has CareDx's enterprise value changed year-over-year?
CareDx's enterprise value decreased by 9.7% year-over-year, from $924.79M to $835.14M.
What is the long-term trend for CareDx's enterprise value?
Over 5 years (2020 to 2025), CareDx's enterprise value has grown at a -24.2% compound annual growth rate (CAGR), from $3.71B to $929.2M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.